ATE202467T1 - Neue zusammensetzung - Google Patents

Neue zusammensetzung

Info

Publication number
ATE202467T1
ATE202467T1 AT94931943T AT94931943T ATE202467T1 AT E202467 T1 ATE202467 T1 AT E202467T1 AT 94931943 T AT94931943 T AT 94931943T AT 94931943 T AT94931943 T AT 94931943T AT E202467 T1 ATE202467 T1 AT E202467T1
Authority
AT
Austria
Prior art keywords
new composition
composition
new
Prior art date
Application number
AT94931943T
Other languages
English (en)
Inventor
Harvey Lee Zimmerman
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303736&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE202467(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939321876A external-priority patent/GB9321876D0/en
Priority claimed from GB939322288A external-priority patent/GB9322288D0/en
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE202467T1 publication Critical patent/ATE202467T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94931943T 1993-10-22 1994-10-20 Neue zusammensetzung ATE202467T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939321876A GB9321876D0 (en) 1993-10-22 1993-10-22 Novel composition
GB939322288A GB9322288D0 (en) 1993-10-29 1993-10-29 Novel composition
PCT/US1994/012026 WO1995010999A1 (en) 1993-10-22 1994-10-20 Novel composition

Publications (1)

Publication Number Publication Date
ATE202467T1 true ATE202467T1 (de) 2001-07-15

Family

ID=26303736

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94931943T ATE202467T1 (de) 1993-10-22 1994-10-20 Neue zusammensetzung

Country Status (27)

Country Link
US (1) US6025389A (de)
EP (1) EP0727979B1 (de)
JP (1) JPH09506865A (de)
KR (1) KR100374462B1 (de)
CN (1) CN1102410C (de)
AP (1) AP608A (de)
AT (1) ATE202467T1 (de)
AU (1) AU692486B2 (de)
BG (1) BG62912B1 (de)
BR (1) BR9407840A (de)
CA (1) CA2174658C (de)
CZ (1) CZ292223B6 (de)
DE (1) DE69427589T2 (de)
DK (1) DK0727979T3 (de)
ES (1) ES2157996T3 (de)
FI (1) FI116931B (de)
GR (1) GR3036591T3 (de)
HU (1) HU221853B1 (de)
NO (1) NO313446B1 (de)
NZ (1) NZ275282A (de)
OA (1) OA10361A (de)
PL (1) PL177592B1 (de)
PT (1) PT727979E (de)
RO (1) RO112987B1 (de)
SK (1) SK280222B6 (de)
UA (1) UA39896C2 (de)
WO (1) WO1995010999A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000048812A (ko) * 1996-10-01 2000-07-25 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 병원성 유기체에 의한 비인두 전이증식 관련 세균 감염 치료용약제를 제조하기 위한 뮤피로신의 용도
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
WO1999012520A1 (en) * 1997-09-11 1999-03-18 Smithkline Beecham Plc Compositions adapted for prolonged residence in the nasal pharynx
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
EP1619947A4 (de) * 2003-05-01 2006-05-31 Replidyne Inc Antibakterielle verfahren und zusammensetzungen
US20050123575A1 (en) * 2003-12-03 2005-06-09 Eilon Asculai Spreadable compositions for topical use, an improved process of making same and methods of using same
WO2008007182A2 (en) * 2006-07-07 2008-01-17 Glenmark Pharmaceuticals Limited Topical pharmaceutical compositions of mupirocin or pharmaceutically acceptable salts or esters thereof
HUE041512T2 (hu) 2010-03-30 2019-05-28 Helperby Therapeutics Ltd Új kombináció és alkalmazás
JP2013532716A (ja) 2010-08-05 2013-08-19 ヘルパービー セラピューティクス リミテッド ピロロキノリン化合物と、β−ラクタム系抗微生物剤、ムピロシンまたはクロルヘキシジンとの組み合わせ
GB201013207D0 (en) 2010-08-05 2010-09-22 Helperby Therapeutics Ltd Novel combination
GB201015079D0 (en) 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
JP2013538868A (ja) 2010-10-08 2013-10-17 ヘルパービー セラピューティクス リミテッド 新規な組成物
ES2702490T3 (es) 2011-05-03 2019-03-01 Dupont Nutrition Biosci Aps Bacterias probióticas para el tratamiento tópico de trastornos de la piel
GB201107755D0 (en) 2011-05-10 2011-06-22 Helperby Therapeutics Ltd Novel compounds
CN102335122B (zh) * 2011-06-21 2013-04-17 北京协和药厂 一种莫匹罗星软膏及其制备方法
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
GB201305277D0 (en) 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
GB201307989D0 (en) 2013-05-02 2013-06-12 Helperby Therapeutics Ltd Novel combinations and use
CA2933081C (en) * 2013-12-17 2023-04-04 Hatchtech Pty Ltd. Pediculicidal composition
GB201401617D0 (en) 2014-01-30 2014-03-19 Helperby Therapeutics Ltd Novel combination and use
CN107530397A (zh) 2014-12-18 2018-01-02 赫尔普百治疗有限公司 新型组合和用途
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
GB201518969D0 (en) 2015-10-27 2015-12-09 Helperby Therapeutics Ltd Triple combination
GB201620095D0 (en) 2016-11-28 2017-01-11 Terali Innov Sas And Univ De Strasbourg And Inserm (Inst Nat De La Sante Et De La Rech Medicale) And Novel use
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
EP3445330B1 (de) 2016-04-19 2022-07-06 The U.S.A. as represented by the Secretary, Department of Health and Human Services Verwendung von gramnegativen spezies zur behandlung von atopischer dermatitis
GB201610869D0 (en) 2016-06-22 2016-08-03 Helperby Therapeutics Ltd Combination
GB201709193D0 (en) 2017-06-09 2017-07-26 Helperby Therapeutics Ltd Combination
WO2019141957A1 (en) 2018-01-19 2019-07-25 Cado Biotechnology Ivs N-pyrimidinyl hydroxy pyrazole derivatives and uses thereof
SG11202011188SA (en) 2018-05-11 2020-12-30 Forte Subsidiary Inc Compositions for the treatment of skin conditions
US10709663B2 (en) 2018-10-17 2020-07-14 Glenmark Pharmaceuticals, Inc., Usa Mupirocin cream in pump device
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
US20210299019A1 (en) * 2020-03-31 2021-09-30 Chemistryrx Methods for treating hyperpigmentation and compositions for same
WO2022207721A1 (en) 2021-03-30 2022-10-06 Dupont Nutrition Biosciences Aps Compositions and methods for treating and preventing gastrointestinal inflammation
WO2025080755A1 (en) 2023-10-13 2025-04-17 Nutrition & Biosciences USA 4, Inc. Methods and compositions for aging and mitochondrial health

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
NZ200918A (en) * 1981-07-02 1985-07-31 Gist Brocades Nv Stable fatty oil-in-water emulsion cream for topical application
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US4847068A (en) * 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions

Also Published As

Publication number Publication date
PT727979E (pt) 2001-11-30
HUT74510A (en) 1997-01-28
CZ112096A3 (en) 1996-07-17
UA39896C2 (uk) 2001-07-16
PL177592B1 (pl) 1999-12-31
NO313446B1 (no) 2002-10-07
FI961720A0 (fi) 1996-04-19
CN1135715A (zh) 1996-11-13
WO1995010999A1 (en) 1995-04-27
NO961588L (no) 1996-04-19
AP608A (en) 1997-08-28
BG62912B1 (bg) 2000-11-30
NO961588D0 (no) 1996-04-19
GR3036591T3 (en) 2001-12-31
CZ292223B6 (cs) 2003-08-13
KR100374462B1 (ko) 2003-06-09
CA2174658A1 (en) 1995-04-27
NZ275282A (en) 1996-10-28
DE69427589D1 (de) 2001-08-02
BR9407840A (pt) 1997-05-13
SK280222B6 (sk) 1999-10-08
FI961720L (fi) 1996-04-19
DK0727979T3 (da) 2001-10-01
HU221853B1 (hu) 2003-02-28
SK49596A3 (en) 1997-02-05
HK1012284A1 (en) 1999-07-30
ES2157996T3 (es) 2001-09-01
RO112987B1 (ro) 1998-03-30
CA2174658C (en) 2000-12-19
BG100501A (bg) 1996-12-31
DE69427589T2 (de) 2002-04-25
EP0727979A1 (de) 1996-08-28
US6025389A (en) 2000-02-15
EP0727979B1 (de) 2001-06-27
HU9601030D0 (en) 1996-06-28
FI116931B (fi) 2006-04-13
AP9600798A0 (en) 1996-04-30
EP0727979A4 (de) 1996-11-27
AU692486B2 (en) 1998-06-11
JPH09506865A (ja) 1997-07-08
OA10361A (en) 2001-11-21
CN1102410C (zh) 2003-03-05
AU8084794A (en) 1995-05-08
PL314038A1 (en) 1996-08-05

Similar Documents

Publication Publication Date Title
DE69427589D1 (de) Neue zusammensetzung
DE69434993D1 (de) Neue harzzusammensetzung
FI931738L (fi) Teknisk harts-propenymppolymerkomposition
DE69325158D1 (de) Photokromische Zusammensetzung
DE69526966D1 (de) Hautkräftigende kometische zusammensetzung
DE69412344D1 (de) Kraftstoffezusammensetzung
FI953499L (fi) Polttoainekoostumus
FI944515L (fi) Päällystyskoostumus
DE69423670D1 (de) Siloxy-aluminoxan-Zusammensetzungen
FI955645A7 (fi) Polyesterikoostumus
FI932957L (fi) Glasfiberfoerstaerkt propenylpolymerkomposition
DE69425786D1 (de) Photoresistzusammensetzung
FI954773A0 (fi) Antihypertriglyserideeminen koostumus
DE69430033D1 (de) Neue Treibzusammensetzung
DE69536102D1 (de) Neue streptogramine
DE69323811D1 (de) Neue Polymermischungen
DE69427938D1 (de) Neue Treibmittelzusammensetzung
DE69428788D1 (de) Parfumzusammensetzung
ITMI940362A0 (it) Composizione antitosse
DE69427365D1 (de) Neue cephalosporinderivate
DE69411083D1 (de) Kraftstoffzusammensetzung
DE69426271D1 (de) Geruchsbeständige Beschichtungszusammensetzung
DE69217904D1 (de) Zusammensetzung
KR950703340A (ko) 항엠알에스에이 조성물
DE59301495D1 (de) Neue Kältemittelzusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification